BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37637433)

  • 1. Doubly robust estimators for generalizing treatment effects on survival outcomes from randomized controlled trials to a target population.
    Lee D; Yang S; Wang X
    J Causal Inference; 2022; 10(1):415-440. PubMed ID: 37637433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving trial generalizability using observational studies.
    Lee D; Yang S; Dong L; Wang X; Zeng D; Cai J
    Biometrics; 2023 Jun; 79(2):1213-1225. PubMed ID: 34862966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collaborative double robust targeted maximum likelihood estimation.
    van der Laan MJ; Gruber S
    Int J Biostat; 2010 May; 6(1):Article 17. PubMed ID: 20628637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical inference for data-adaptive doubly robust estimators with survival outcomes.
    Díaz I
    Stat Med; 2019 Jul; 38(15):2735-2748. PubMed ID: 30950107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Data-Adaptive Bias-Reduced Doubly Robust Estimation.
    Vermeulen K; Vansteelandt S
    Int J Biostat; 2016 May; 12(1):253-82. PubMed ID: 27227724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the Relation Between G-formula and Inverse Probability Weighting Estimators for Generalizing Trial Results.
    Dahabreh IJ; Robertson SE; Hernán MA
    Epidemiology; 2019 Nov; 30(6):807-812. PubMed ID: 31517670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple, doubly robust, efficient estimator for survival functions using pseudo observations.
    Wang J
    Pharm Stat; 2018 Feb; 17(1):38-48. PubMed ID: 29094501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doubly robust inference for targeted minimum loss-based estimation in randomized trials with missing outcome data.
    Díaz I; van der Laan MJ
    Stat Med; 2017 Oct; 36(24):3807-3819. PubMed ID: 28744883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double Robust Efficient Estimators of Longitudinal Treatment Effects: Comparative Performance in Simulations and a Case Study.
    Tran L; Yiannoutsos C; Wools-Kaloustian K; Siika A; van der Laan M; Petersen M
    Int J Biostat; 2019 Feb; 15(2):. PubMed ID: 30811344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalizing trial evidence to target populations in non-nested designs: Applications to AIDS clinical trials.
    Li F; Buchanan AL; Cole SR
    J R Stat Soc Ser C Appl Stat; 2022 Jun; 71(3):669-697. PubMed ID: 35968541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doubly-robust estimator of the difference in restricted mean times lost with competing risks data.
    Lin J; Trinquart L
    Stat Methods Med Res; 2022 Oct; 31(10):1881-1903. PubMed ID: 35607287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doubly robust estimation and sensitivity analysis for marginal structural quantile models.
    Cheng C; Hu L; Li F
    Biometrics; 2024 Mar; 80(2):. PubMed ID: 38884127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doubly robust nonparametric instrumental variable estimators for survival outcomes.
    Lee Y; Kennedy EH; Mitra N
    Biostatistics; 2023 Apr; 24(2):518-537. PubMed ID: 34676400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doubly-robust methods for differences in restricted mean lifetimes using pseudo-observations.
    Choi S; Choi T; Lee HY; Han SW; Bandyopadhyay D
    Pharm Stat; 2022 Nov; 21(6):1185-1198. PubMed ID: 35524651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model misspecification and robustness in causal inference: comparing matching with doubly robust estimation.
    Waernbaum I
    Stat Med; 2012 Jul; 31(15):1572-81. PubMed ID: 22359267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sufficient Dimension Reduction for Feasible and Robust Estimation of Average Causal Effect.
    Ghosh T; Ma Y; de Luna X
    Stat Sin; 2021 Apr; 31(2):821-842. PubMed ID: 34526756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doubly robust inference when combining probability and non-probability samples with high dimensional data.
    Yang S; Kim JK; Song R
    J R Stat Soc Series B Stat Methodol; 2020 Apr; 82(2):445-465. PubMed ID: 33162780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonparametric inverse-probability-weighted estimators based on the highly adaptive lasso.
    Ertefaie A; Hejazi NS; van der Laan MJ
    Biometrics; 2023 Jun; 79(2):1029-1041. PubMed ID: 35839293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An alternative empirical likelihood method in missing response problems and causal inference.
    Ren K; Drummond CA; Brewster PS; Haller ST; Tian J; Cooper CJ; Zhang B
    Stat Med; 2016 Nov; 35(27):5009-5028. PubMed ID: 27417265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.